GO:0140313 molecular sequestering activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0140313 molecular sequestering activity is a molecular function defined as binding to a specific molecule to prevent it from interacting with other partners or to inhibit its localization to the area of the cell or complex where it is active.
• Molecular sequestering activity is used across diverse biological contexts, including actin monomer buffering by beta-thymosins, proteasome activator regulation, phage anti-immune signaling [3,8], prelamin A processing in lipodystrophy, iron sequestration in tumor immunity, mitotic telomere protection, and phosphatidylserine exposure.
• The function is not a single pathway but a mechanistic strategy: a sequestering protein binds a target and blocks its interaction or localization, thereby acting as a buffer, sink, or timer.
• Dysregulation of sequestering interactions contributes to human disease, including lipodystrophy via prelamin A sequestration defects and cancer-related immune evasion through altered iron handling.
• CRISPR knockout, point-mutation, knock-in, and overexpression models are essential to test whether a candidate sequestering protein is causally required for a phenotype.
• EDITGENE provides end-to-end CRISPR cell model generation and library screening to dissect molecular sequestering activity at scale.
Description
GO:0140313 molecular sequestering activity is a molecular function in which a protein or other molecule binds a specific target to prevent that target from interacting with its normal partners or to inhibit its localization to the cellular area or complex where it would normally act. This definition, from the Gene Ontology, captures a widespread regulatory strategy in which binding itself is the function, rather than catalysis or transport. Researchers encounter molecular sequestering activity whenever a factor is held in reserve, kept away from a substrate, or prevented from reaching a site of action [1,2,3]. The term is deliberately broad because the same biochemical logic applies to actin monomer buffering by beta-thymosins, inhibition of proteasome activators, and phage proteins that sequester immune signaling molecules [3,8]. In each case, the sequestering protein acts as a buffer, sink, or timer that tunes the availability of an active molecule. Because sequestering events often control the timing and location of downstream processes, they are central to cell division, immune signaling, nuclear architecture, and membrane dynamics [4,5,6,7]. For researchers, GO:0140313 provides a precise annotation for proteins whose primary role is to hold a target in an inactive or mislocalized state, distinguishing them from enzymes, transporters, and structural components. Understanding molecular sequestering activity therefore requires both binding data and functional evidence that the interaction blocks a downstream event. This article reviews the mechanism, key genes, disease links, and experimental methods used to study GO:0140313, with an emphasis on CRISPR-based models that can test causality.
molecular sequestering activity At A Glance
| GO ID | GO:0140313 |
|---|---|
| GO term | molecular sequestering activity |
| Ontology | molecular_function |
| Synonym | none |
| Definition | Binding to a specific molecule to prevent it from interacting with other partners or to inhibit its localization to the area of the cell or complex where it is active. |
| Major function | Buffering, sinking, or timing the availability of a target molecule by binding and blocking its interactions or localization. |
| Representative targets | Actin monomers, proteasome activators, immune signaling molecules, prelamin A processing intermediates, iron, telomere factors, phosphatidylserine. |
| Cellular contexts | Cytoplasm, nucleus, proteasome, cell division machinery, immune signaling complexes, membrane leaflets. |
| Research relevance | Controls cell division, immune signaling, nuclear architecture, membrane dynamics, and disease-related pathways. |
What Is GO:0140313?
In plain terms, molecular sequestering activity means a molecule grabs a specific partner and keeps it away from where it would normally work. The official Gene Ontology definition is binding to a specific molecule to prevent it from interacting with other partners or to inhibit its localization to the area of the cell or complex where it is active. This function is distinct from simple binding because the consequence is blockade: the sequestered target cannot engage its usual interactors or reach its active site. Examples include beta-thymosins that bind actin monomers to prevent polymerization, proteasome activators that are themselves regulated by sequestering interactions, and phage proteins that sequester host immune signals [3,8]. The function can be reversible or irreversible, and it can operate as a buffer, a sink, or a timing device. Because the definition focuses on the outcome of binding, experimental validation requires showing that the interaction prevents a downstream molecular event or changes target localization [4,5,6,7].
Why Is molecular sequestering activity Important in Cell Biology?
Molecular sequestering activity matters because it provides a general mechanism for regulating the availability of active molecules without changing their synthesis or degradation. By binding a target and preventing its interactions or localization, sequestering proteins can set thresholds, create delays, and protect cells from premature or inappropriate activation [1,2,3]. This function is important in actin dynamics, where beta-thymosins buffer monomeric actin, in proteasome regulation, in anti-phage immunity [3,8], in nuclear lamina processing and lipodystrophy, in tumor immunity through iron sequestration, in mitotic telomere protection, and in phosphatidylserine exposure. Because sequestering events are often reversible and context-dependent, they are attractive targets for experimental perturbation and therapeutic intervention. Researchers studying GO:0140313 need methods that measure binding, localization, and downstream activity, and CRISPR models are particularly useful for testing causality.
• Provides a general regulatory strategy for buffering or timing the availability of active molecules [1,2].
• Controls actin monomer availability and cytoskeletal dynamics through beta-thymosins.
• Regulates proteasome activator function and protein degradation capacity.
• Enables phage proteins to sequester host immune signals and modulate immunity [3,8].
• Links prelamin A processing defects to lipodystrophy and nuclear architecture.
• Supports antitumor immunity by sequestering iron in tumor macrophages.
• Protects telomeres during mitosis through a CPC-shelterin-BTR axis.
• Regulates phosphatidylserine exposure and membrane signaling.
• Offers a mechanistic explanation for diseases caused by loss or gain of sequestering interactions [4,5].
• Creates opportunities for CRISPR-based functional dissection and therapeutic targeting.
Molecular sequestering activity: mechanism, components, and regulation
Target recognition and binding
In simple terms: The sequestering protein first finds and binds its specific target.
The first step in molecular sequestering activity is specific recognition of the target molecule. This binding can occur through structured interfaces or short linear motifs, and it determines which partner is sequestered. For example, beta-thymosins bind actin monomers to prevent their incorporation into filaments. Proteasome activators are regulated by interactions that can sequester them from the proteasome. Phage proteins can bind and sequester host immune signaling molecules, blocking their downstream functions [3,8]. The specificity of this step is what distinguishes molecular sequestering activity from nonspecific aggregation or general chaperone activity.
Blocking interactions or localization
In simple terms: Once bound, the target cannot interact with its normal partners or reach its usual location.
The defining consequence of molecular sequestering activity is blockade. The sequestered target is prevented from interacting with other partners or from localizing to the area of the cell or complex where it is active. This can occur by steric occlusion, conformational trapping, or physical tethering away from the active site. In the case of prelamin A processing, altered processing can lead to accumulation of intermediates that affect nuclear function and contribute to lipodystrophy. In immune signaling, phage proteins that sequester TIR and cGAS-like enzymes prevent activation of antiviral pathways. In mitotic cells, a CPC-shelterin-BTR axis regulates telomere deprotection, illustrating how sequestering-like interactions control localization and protection.
Buffering, sink, and timer functions
In simple terms: Sequestering proteins can act as buffers, sinks, or timers that tune when and where a target acts.
Molecular sequestering activity can serve different kinetic roles. As a buffer, the sequestering protein reversibly binds a target and keeps its free concentration low, as seen with beta-thymosins and actin monomers. As a sink, it can irreversibly or tightly remove a target from the available pool, as proposed for iron sequestration in tumor macrophages. As a timer, it can delay a process until a signal releases the target, a logic observed in immune signaling where sequestering proteins block signal transduction until relieved [3,8]. These roles are context-dependent and often require quantitative measurements of binding and free target concentration.
Release and reversibility
In simple terms: Many sequestering interactions can be reversed, allowing the target to become active again.
Reversibility is a key feature of many molecular sequestering events. Phosphatidylserine exposure is regulated by flippases and scramblases, which control the localization of this lipid and its availability for signaling. In proteasome regulation, activator availability can be modulated by sequestering interactions that are relieved under specific conditions. In mitotic telomere protection, the CPC-shelterin-BTR axis dynamically regulates deprotection, suggesting that sequestering-like interactions can be reversed to allow access. Understanding release mechanisms is essential for predicting how cells switch between sequestered and active states.
Integration with cellular pathways
In simple terms: Sequestering activity is wired into larger pathways that control cell behavior.
Molecular sequestering activity does not operate in isolation. It is integrated with cytoskeletal dynamics, protein degradation, immune signaling, nuclear architecture, and membrane biology [1,2,3,4,5,6,7,8]. For example, actin buffering by beta-thymosins influences cell motility and shape, while iron sequestration in tumor macrophages shapes antitumor immunity. Phage proteins that sequester immune signals can determine the outcome of bacterial infection [3,8]. This integration means that perturbations of sequestering proteins can have pleiotropic effects, and researchers must interpret phenotypes in the context of the relevant pathway.
Key Genes Involved in GO:0140313 molecular sequestering activity
The following genes and proteins represent diverse examples of molecular sequestering activity across cellular contexts, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TMSB4X | Beta-thymosin that binds actin monomers and prevents polymerization | Model for actin buffering and cytoskeletal regulation |
| TMSB10 | Beta-thymosin family member involved in actin sequestration | Study of actin dynamics and cell motility |
| PSME1 | Proteasome activator subunit regulated by sequestering interactions | Proteasome regulation and degradation capacity |
| PSME2 | Proteasome activator subunit with sequestering-like regulation | Protein degradation and immune function |
| PSME3 | Proteasome activator involved in complex regulation | Proteasome biology and cancer |
| TIR | Immune signaling domain sequestered by phage proteins | Anti-phage immunity and signal transduction |
| cGAS | Enzyme targeted by phage sequestering proteins | Innate immune signaling and phage defense |
| LMNA | Prelamin A processing affected by sequestering defects | Lipodystrophy and nuclear lamina biology |
| ZMPSTE24 | Protease involved in prelamin A processing | Lipodystrophy and nuclear architecture |
| SLC40A1 | Iron exporter relevant to iron sequestration in macrophages | Tumor immunity and iron metabolism |
| FTH1 | Ferritin heavy chain involved in iron storage and sequestration | Iron sequestration and antitumor immunity |
| FTL | Ferritin light chain involved in iron storage | Iron handling and immune regulation |
| TERF2 | Shelterin component in telomere protection | Mitotic telomere deprotection and genome stability |
| TERF2IP | Shelterin-associated factor in telomere regulation | Telomere protection and cell division |
| ANO6 | Scramblase involved in phosphatidylserine exposure | Membrane dynamics and immune signaling |
| ATP11A | Flippase regulating phosphatidylserine localization | Membrane asymmetry and cell signaling |
| FtsZ | Bacterial cell division protein that complexes with phage proteins | Bacterial immunity and cell division |
How Is molecular sequestering activity Regulated?
Molecular sequestering activity is regulated at multiple levels. The availability of the sequestering protein itself can be controlled by transcription, translation, and degradation, while post-translational modifications can alter its binding affinity for the target. In actin regulation, beta-thymosins are regulated by their expression levels and by interactions with other actin-binding proteins. Proteasome activator sequestering is influenced by the composition of proteasome complexes and cellular demand for degradation. Phage-encoded sequestering proteins are expressed during infection and can rapidly block host immune signaling [3,8]. In iron sequestration, macrophage iron handling is regulated by iron transporters and storage proteins such as SLC40A1, FTH1, and FTL. Telomere protection during mitosis is regulated by the CPC-shelterin-BTR axis, which controls when deprotection occurs. Phosphatidylserine exposure is regulated by the opposing activities of flippases and scramblases. These regulatory layers ensure that sequestering activity is tuned to cellular state and environmental cues.
molecular sequestering activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| LMNA | Lipodystrophy and nuclear lamina defects | Knockout or point-mutation cell models to study prelamin A processing |
| ZMPSTE24 | Lipodystrophy and defective prelamin A processing | Knockout cells and rescue with wild-type or mutant protease |
| SLC40A1 | Iron sequestration in tumor macrophages | Knockout macrophages and iron-handling assays |
| FTH1 | Iron storage and antitumor immunity | Overexpression and knockout models for iron sequestration |
| TERF2 | Telomere protection and genome stability | Knockout and tagged knock-in for mitotic telomere assays |
Lipodystrophy and nuclear lamina defects
Altered prelamin A processing is a common mechanism leading to lipodystrophy, and defects in this pathway can be viewed through the lens of molecular sequestering activity, where processing intermediates or interacting factors are mislocalized or prevented from functioning normally. Mutations in LMNA and ZMPSTE24 cause processing defects that affect nuclear architecture and adipose tissue homeostasis. Studying these sequestering-like interactions can reveal how nuclear lamina proteins are held in inactive states and how their release is required for normal differentiation.
Cancer and tumor immunity
A dietary commensal microbe enhances antitumor immunity by activating tumor macrophages to sequester iron, linking molecular sequestering activity to cancer immunology. Iron sequestration in macrophages can limit iron availability to tumor cells and shape the immune microenvironment. This example shows how sequestering activity can be therapeutically relevant and how modulating it may influence tumor progression. Researchers can use CRISPR models to test whether iron-handling genes such as SLC40A1, FTH1, and FTL are required for this effect.
Infectious disease and anti-phage immunity
Phage proteins can sequester signals from TIR and cGAS-like enzymes, and bacterial cell division protein FtsZ can complex with a phage protein to activate bacterial immunity [3,8]. These examples highlight molecular sequestering activity as a battleground in host-pathogen interactions. Understanding how phage proteins block immune signaling may inform new antibacterial strategies and deepen our knowledge of innate immunity [3,8].
Membrane dynamics and immune signaling
Flippases and scramblases regulate phosphatidylserine exposure, a process that depends on controlling the localization of a lipid signal. Dysregulation of phosphatidylserine exposure is linked to immune recognition and cell clearance. Molecular sequestering activity provides a framework for understanding how lipid localization is controlled and how its disruption can contribute to disease.
From molecular sequestering activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate sequestering protein required for target buffering? | CRISPR knockout cell line with target activity assays [1,2] |
| Does a specific binding interface mediate sequestration? | Point-mutation knock-in of the binding interface [3,4] |
| Where does the sequestering protein localize in cells? | Tagged knock-in with fluorescent or epitope tag [6,7] |
| Does overexpression of the sequestering protein phenocopy loss of target activity? | Overexpression cell model with dose-response assays [5,8] |
| Which genes are required for iron sequestration in macrophages? | CRISPR library screening in macrophage models |
| How does a phage protein sequester immune signals? | Bacterial knockout and phage infection models [3,8] |
How to Study the molecular sequestering activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Co-immunoprecipitation | Physical interaction between sequestering protein and target [1,2] | Confirm binding specificity |
| Fluorescence microscopy | Localization of target and sequestering protein [6,7] | Detect mislocalization |
| CRISPR knockout | Requirement of sequestering protein for target regulation [3,4,5] | Test causality |
| Point-mutation knock-in | Role of specific binding interface [3,4] | Dissect binding determinants |
| Overexpression | Sufficiency of sequestering activity [5,8] | Phenocopy target loss |
| CRISPR library screening | Genes required for sequestering-related phenotypes [5,8] | Identify modifiers |
| Proteomics | Protein complexes and interaction networks [2,5] | Map sequestering complexes |
| Iron quantification assays | Iron sequestration capacity | Study macrophage iron handling |
Binding and interaction assays
Biochemical methods such as co-immunoprecipitation, pull-down, and surface plasmon resonance can measure direct binding between a sequestering protein and its target [1,2]. These assays are essential to confirm that the interaction is specific and to map the binding interface. For example, beta-thymosin binding to actin monomers can be assessed by sedimentation and fluorescence methods. Proteasome activator interactions can be studied by native gel and pull-down assays.
Localization and imaging
Fluorescence microscopy and live-cell imaging can determine whether a target is mislocalized when a sequestering protein is present or absent [6,7]. Tagged knock-in models allow visualization of endogenous proteins at physiological levels. For membrane lipids such as phosphatidylserine, specific probes and flippase/scramblase assays can report localization changes. Telomere protection can be monitored by immunofluorescence of telomere factors during mitosis.
Functional perturbation with CRISPR
CRISPR knockout, point mutation, knock-in, and overexpression are powerful ways to test causality in molecular sequestering activity [3,4,5,8]. Knockout removes the sequestering protein and tests whether the target becomes inappropriately active. Point mutations can disrupt a specific binding interface without affecting protein levels. Knock-in tags enable localization studies, and overexpression can test sufficiency. These approaches are particularly useful when the sequestering protein has pleiotropic roles.
Omics and screening
Transcriptomics, proteomics, and CRISPR library screening can identify pathways and genes that cooperate with molecular sequestering activity [5,8]. For example, iron sequestration in tumor macrophages can be studied by profiling iron-handling genes and testing candidates in pooled screens. Phage-host interactions can be dissected by bacterial CRISPR screens and phage infection assays [3,8]. These methods provide a systems-level view of how sequestering activity integrates with cellular networks.
How CRISPR Can Be Used to Study GO:0140313 molecular sequestering activity
Knockout
CRISPR knockout is used to delete a candidate sequestering gene and test whether its target becomes inappropriately active or mislocalized. For example, knocking out beta-thymosin genes can reveal effects on actin polymerization. Knocking out proteasome activator genes can alter degradation capacity. In bacterial systems, knocking out FtsZ or phage proteins can reveal their role in immunity. Knockout models are the first step in establishing causality for GO:0140313.
Point Mutation
Point-mutation knock-in can disrupt a specific binding interface while preserving protein expression. This is useful when complete knockout causes pleiotropic effects. For instance, mutating the actin-binding region of a beta-thymosin can test whether sequestration of actin monomers is required for its function. Similarly, mutating phage protein residues that contact immune signaling domains can test the specificity of sequestration.
Knock-in
Knock-in of tags or reporters allows visualization and biochemical isolation of endogenous sequestering proteins. Tagged knock-in of shelterin components can reveal their dynamics during mitosis. Tagged knock-in of flippases or scramblases can track their localization and activity. These models are valuable for studying molecular sequestering activity in a physiological context.
Overexpression
Overexpression of a sequestering protein can test whether increased sequestration is sufficient to produce a phenotype. For example, overexpressing iron storage proteins can enhance iron sequestration in macrophages. Overexpressing phage proteins can block immune signaling more strongly [3,8]. Overexpression models complement loss-of-function studies and help define the dose-response of sequestering activity.
How EDITGENE Supports molecular sequestering activity Research
Researchers studying molecular sequestering activity-related genes often need to determine whether a candidate gene is causally involved in buffering, localizing, or blocking a target molecule. This requires precise genetic models that can distinguish binding from downstream effects. EDITGENE provides CRISPR-based cell models and screening services tailored to these questions.
Contact EDITGENE today to design your custom CRISPR model for molecular sequestering activity research.
Frequently Asked Questions About molecular sequestering activity
What is molecular sequestering activity?
Molecular sequestering activity (GO:0140313) is a molecular function defined as binding to a specific molecule to prevent it from interacting with other partners or to inhibit its localization to the area of the cell or complex where it is active.
What genes are involved in molecular sequestering activity?
Genes include TMSB4X and TMSB10 for actin buffering, PSME1/2/3 for proteasome regulation, TIR and cGAS for immune signaling, LMNA and ZMPSTE24 for prelamin A processing, SLC40A1, FTH1, and FTL for iron sequestration, TERF2 and TERF2IP for telomere protection, ANO6 and ATP11A for phosphatidylserine regulation, and FtsZ for bacterial immunity.
How is molecular sequestering activity different from simple binding?
Simple binding describes an interaction, whereas molecular sequestering activity specifically requires that the binding prevents the target from interacting with other partners or from localizing to its active site.
What diseases are linked to molecular sequestering activity?
Diseases include lipodystrophy linked to prelamin A processing defects, cancer and tumor immunity linked to iron sequestration, and infectious disease processes involving phage immune evasion [3,8].
How can I study molecular sequestering activity in the lab?
Common methods include co-immunoprecipitation, fluorescence microscopy, CRISPR knockout, point-mutation knock-in, overexpression, and CRISPR library screening [1,2,3,4,5,6,7,8].
What is the role of beta-thymosins in molecular sequestering activity?
Beta-thymosins bind actin monomers and prevent their polymerization, acting as buffers of actin availability.
Can CRISPR knockout help identify sequestering proteins?
Yes, CRISPR knockout can remove a candidate sequestering protein and reveal whether its target becomes inappropriately active or mislocalized [1,2,3,8].
What is the GO ID for molecular sequestering activity?
The GO ID is GO:0140313.
Is molecular sequestering activity a molecular function or a biological process?
It is a molecular function in the Gene Ontology, meaning it describes an activity at the molecular level rather than a whole pathway.
How does iron sequestration relate to cancer immunity?
A dietary commensal microbe can activate tumor macrophages to sequester iron, enhancing antitumor immunity.
Conclusion
GO:0140313 molecular sequestering activity captures a fundamental regulatory strategy in which binding blocks a target from interacting or localizing correctly. From actin buffering by beta-thymosins to proteasome regulation, phage immune evasion [3,8], prelamin A processing, iron sequestration in tumor immunity, telomere protection, and phosphatidylserine exposure, this function appears across diverse biological systems. Understanding its mechanism requires binding, localization, and functional assays, and CRISPR models are essential for testing causality. EDITGENE offers comprehensive CRISPR services to accelerate research on molecular sequestering activity and its role in health and disease.
References
- 1. Hannappel E. 2007. beta-Thymosins.. Ann N Y Acad Sci 1112:21-37 PMID: 17468232
- 2. Stadtmueller BM et al.. 2011. Proteasome activators.. Mol Cell 41(1):8-19 PMID: 21211719
- 3. Li D et al.. 2024. Single phage proteins sequester signals from TIR and cGAS-like enzymes.. Nature 635(8039):719-727 PMID: 39478223
- 4. Capanni C et al.. 2005. Altered pre-lamin A processing is a common mechanism leading to lipodystrophy.. Hum Mol Genet 14(11):1489-502 PMID: 15843404
- 5. Sharma G et al.. 2024. A dietary commensal microbe enhances antitumor immunity by activating tumor macrophages to sequester iron.. Nat Immunol 25(5):790-801 PMID: 38664585
- 6. Romero-Zamora D et al.. 2025. A CPC-shelterin-BTR axis regulates mitotic telomere deprotection.. Nat Commun 16(1):2277 PMID: 40097392
- 7. Nagata S et al.. 2020. Flippase and scramblase for phosphatidylserine exposure.. Curr Opin Immunol 62:31-38 PMID: 31837595
- 8. Zhang T et al.. 2026. Bacterial cell division protein FtsZ complexes with a phage protein to activate bacterial immunity.. Nat Microbiol 11(8):2266-2278 PMID: 42286244
